This article describes a set of 275 rules, developed over an 18-year period, used to identify compounds that may interfere with biological assays, allowing their removal from screening sets. Reasons for rejection include reactivity (e.g., acyl halides), interference with assay measurements (fluorescence, absorbance, quenching), activities that damage proteins (oxidizers, detergents), instability (e.g., latent aldehydes), and lack of druggability (e.g., compounds lacking both oxygen and nitrogen). The structural queries were profiled for frequency of occurrence in druglike and nondruglike compound sets and were extensively reviewed by a panel of experienced medicinal chemists. As a means of profiling the rules and as a filter in its own righ...
ABSTRACT: Significant resources in early drug discovery are spent unknowingly pursuing artifacts and...
Compounds that exhibit assay interference or undesirable mechanisms of bioactivity (“nuisance compou...
The ability of target proteins to bind structurally diverse compounds and compounds with different d...
This article describes a set of 275 rules, developed over an 18-year period, used to identify compou...
A database of 1070 marketed drug compounds was compiled and analyzed in order to assess the occurren...
Abstract: It is recognized that high-throughput enzyme inhibition screens often return nonspecific i...
Scientists rely on high-throughput screening tools to identify promising small-molecule compounds fo...
In the context of polypharmacology, an emerging concept in drug discovery, promiscuity is rationaliz...
This study presents an analysis of the small molecule bioactivity profiles across large quantities o...
This study presents an analysis of the small molecule bioactivity profiles across large quantities o...
This study presents an analysis of the small molecule bioactivity profiles across large quantities o...
Biochemical assay interference is becoming increasingly recognized as a significant waste of resourc...
<p> </p> <p>In the last 6 years high-throughput screening has been used to identify FDA approved dru...
Compounds with apparent activity in a variety of assays might disable target proteins or produce fal...
<p>For the pool of 466 detected highly promiscuous compounds the PubChem ID and the corresponding Ch...
ABSTRACT: Significant resources in early drug discovery are spent unknowingly pursuing artifacts and...
Compounds that exhibit assay interference or undesirable mechanisms of bioactivity (“nuisance compou...
The ability of target proteins to bind structurally diverse compounds and compounds with different d...
This article describes a set of 275 rules, developed over an 18-year period, used to identify compou...
A database of 1070 marketed drug compounds was compiled and analyzed in order to assess the occurren...
Abstract: It is recognized that high-throughput enzyme inhibition screens often return nonspecific i...
Scientists rely on high-throughput screening tools to identify promising small-molecule compounds fo...
In the context of polypharmacology, an emerging concept in drug discovery, promiscuity is rationaliz...
This study presents an analysis of the small molecule bioactivity profiles across large quantities o...
This study presents an analysis of the small molecule bioactivity profiles across large quantities o...
This study presents an analysis of the small molecule bioactivity profiles across large quantities o...
Biochemical assay interference is becoming increasingly recognized as a significant waste of resourc...
<p> </p> <p>In the last 6 years high-throughput screening has been used to identify FDA approved dru...
Compounds with apparent activity in a variety of assays might disable target proteins or produce fal...
<p>For the pool of 466 detected highly promiscuous compounds the PubChem ID and the corresponding Ch...
ABSTRACT: Significant resources in early drug discovery are spent unknowingly pursuing artifacts and...
Compounds that exhibit assay interference or undesirable mechanisms of bioactivity (“nuisance compou...
The ability of target proteins to bind structurally diverse compounds and compounds with different d...